Abstract
Authors Xiangsheng Liu, Yu-Pei Liao, Xiang Wang, AymanAhmed, Ying Ji, Huan Meng, Andre E. Nel, and the Editor retract this work due to the inability to reproduce the claimed nanocarrier in the 4T1 breast cancer model. The authors suggest that the lysophosphatidylcholine prodrug has detergent-like properties that may disrupt the lipid bilayer. However, based on the inability to reproduce this nanocarrier, the authors retract the work, although the first author disagrees with the retraction. The original article was published on October 16, 2018 and retracted on May 21, 2021.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 10735 |
| Number of pages | 1 |
| Journal | ACS Nano |
| Volume | 15 |
| Issue number | 6 |
| DOIs |
|
| State | Published - Jun 22 2021 |
ASJC Scopus subject areas
- General Materials Science
- General Engineering
- General Physics and Astronomy
Fingerprint
Dive into the research topics of 'Retraction: Breast Cancer Chemo-immunotherapy through Liposomal Delivery of an Immunogenic Cell Death Stimulus plus Interference in the IDO-1 Pathway (ACS Nano (2018) 12:11 (11041−11061) DOI: 10.1021/acsnano.8b05189)'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS